US corporate tax offer to the world, ShareChat valued at $2.1bn, Vaccitech IPO
The start-up that owns the biotechnology behind the Oxford/AstraZeneca vaccine has confidentially filed for an initial public offering in the US, Indian social media group ShareChat has raised more than $500m to grow its popular short-video app Moj, and Austrian activist Max Schrems has filed a privacy complaint…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like FT News Briefing →
China's race to tech supremacy: Driving into Europe
Hawks, stocks and peril: Iran-America brinkmanship
America sues Apple
Apple goes to war with Facebook and Google
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.